Pharmacological Activity and Mechanism of Tanshinone IIA in Related Diseases

References

• LiMH, ChenJM, PengY, WuQ, XiaoPG. Investigation of Danshen and related medicinal plants in China. J Ethnopharmacol. 2008;120(3):419–426. doi:10.1016/j.jep.2008.09.01318930799
   PubMed Web of Science ®Google Scholar
• HaoD-C, GeG-B, XiaoP-G. Anticancer drug targets of salvia phytometabolites: chemistry, biology and omics. Curr Drug Targets. 2018;19:1. doi:10.2174/138945011766616120714102027924725
   PubMed Web of Science ®Google Scholar
• UtoT, TungNH, OhtaT, et al. Antiproliferative activity and apoptosis induction by trijuganone C isolated from the root of Salvia miltiorrhiza Bunge (Danshen). Phytother Res. 2018;32(4):657–666. doi:10.1002/ptr.601329464799
   PubMed Web of Science ®Google Scholar
• ZhouR, HeL-F, LiY-J, ShenY, ChaoR-B, DuJ-R. Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. J Ethnopharmacol. 2012;139(2):440–446. doi:10.1016/j.jep.2011.11.03022138518
   PubMed Web of Science ®Google Scholar
• IrmakF, Kurt YazarS, SirvanSS, SerinM. Beneficial effects of Salvia miltiorrhiza in the healing of burn wounds: an experimental study in rats. J Plast Surg Hand Surg. 2018;52:229–233. doi:10.1080/2000656X.2018.146163129656662
   PubMed Web of Science ®Google Scholar
• FeiY-X, WangS-Q, YangL-J, et al. Salvia miltiorrhiza Bunge (Danshen) extract attenuates permanent cerebral ischemia through inhibiting platelet activation in rats. J Ethnopharmacol. 2017;207:57–66. doi:10.1016/j.jep.2017.06.02328645780
   PubMed Web of Science ®Google Scholar
• HungY-C, PanT-L, HuW-L. Roles of reactive oxygen species in anticancer therapy with salvia miltiorrhiza Bunge. Oxid Med Cell Longev. 2016;2016:5293284. doi:10.1155/2016/529328427579153
   PubMed Web of Science ®Google Scholar
• WangL, MaR, LiuC, et al. Salvia miltiorrhiza: a potential red light to the development of Cardiovascular Diseases. Curr Pharm Des. 2017;23(7):1077–1097. doi:10.2174/138161282266616101010524227748194
   PubMed Web of Science ®Google Scholar
• LinM, QiX, ChenJ, et al. The complete chloroplast genome sequence of Actinidia arguta using the PacBio RS II platform. PLoS One. 2018;13(5):e0197393–e0197393. doi:10.1371/journal.pone.019739329795601
   PubMed Web of Science ®Google Scholar
• HanB, ZhangX, ZhangQ, et al. Protective effects of salvianolate on microvascular flow in a porcine model of myocardial ischaemia and reperfusion. Arch Cardiovasc Dis. 2011;104(5):313–324. doi:10.1016/j.acvd.2011.02.00421693368
   PubMed Web of Science ®Google Scholar
• LiuB, DuY, CongL, JiaX, YangG. Danshen (Salvia miltiorrhiza) compounds improve the biochemical indices of the patients with coronary heart Disease. Evid Based Complement Alternat Med. 2016;2016:9781715. doi:10.1155/2016/978171527366196
   PubMed Web of Science ®Google Scholar
• LiYG, SongL, LiuM, HuZB, WangZT. Advancement in analysis of salviae miltiorrhizae radix et rhizoma (Danshen). J Chromatogr A. 2009;1216(11):1941–1953. doi:10.1016/j.chroma.2008.12.03219159889
   PubMed Web of Science ®Google Scholar
• WangL, LiY, GuoY, et al. Herba epimedii: an ancient chinese herbal medicine in the prevention and treatment of osteoporosis. Curr Pharm Des. 2016;22(3):328–349. doi:10.2174/138161282266615111214590726561074
   PubMed Web of Science ®Google Scholar
• LukasB, NovakJ. The complete chloroplast genome of Origanum vulgare L. (Lamiaceae). Gene. 2013;528(2):163–169. doi:10.1016/j.gene.2013.07.02623911304
   PubMed Web of Science ®Google Scholar
• WuWY, WangYP. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol Sin. 2012;33(9):1119–1130. doi:10.1038/aps.2012.12622941285
   PubMed Web of Science ®Google Scholar
• LingS, LuoR, DaiA, GuoZ, GuoR, KomesaroffPA. A pharmaceutical preparation of Salvia miltiorrhiza protects cardiac myocytes from tumor necrosis factor-induced apoptosis and reduces angiotensin II-stimulated collagen synthesis in fibroblasts. Phytomedicine. 2009;16(1):56–64. doi:10.1016/j.phymed.2008.09.00819010649
   PubMed Web of Science ®Google Scholar
• DowJ, PainovichJ, HaleSL, Tjen-A-LooiS, LonghurstJC, KlonerRA. Absence of actions of commonly used chinese herbal medicines and electroacupuncture on myocardial infarct size. J Cardiovasc Pharmacol Ther. 2012;17(4):403–411. doi:10.1177/107424841244331022549008
   PubMed Web of Science ®Google Scholar
• HartutiED, InaokaDK, KomatsuyaK, et al. Biochemical studies of membrane bound Plasmodium falciparum mitochondrial L-malate: quinone oxidoreductase, a potential drug target. Biochimica et Biophysica Acta. 2018;1859(3):191–200. doi:10.1016/j.bbabio.2017.12.00429269266
   PubMed Web of Science ®Google Scholar
• SchulzCE, DuttaAK, IzsakR, PantazisDA. Systematic high-accuracy prediction of electron affinities for biological quinones. J Comput Chem. 2018;39(29):2439–2451. doi:10.1002/jcc.2557030281169
   PubMed Web of Science ®Google Scholar
• SchmidtS, GonzalezD, DerendorfH. Significance of protein binding in pharmacokinetics and pharmacodynamics. J Pharm Sci. 2010;99(3):1107–1122. doi:10.1002/jps.2191619852037
   PubMed Web of Science ®Google Scholar
• LeriM, ScutoM, OntarioML, et al. Healthy effects of plant polyphenols: molecular mechanisms. Int J Mol Sci. 2020;21:4.
   Web of Science ®Google Scholar
• YasarU. Two-sided action of Danshen on cytoprotective endogenous substances, epoxyeicosatrienoic acids. Chem Biol Interact. 2018;291:152. doi:10.1016/j.cbi.2018.06.02329935162
   PubMed Web of Science ®Google Scholar
• XuS, LiuP. Tanshinone II-A: new perspectives for old remedies. Expert Opin Ther Pat. 2013;23(2):149–153. doi:10.1517/13543776.2013.74399523231009
   PubMed Web of Science ®Google Scholar
• DongXL, YuWX, LiCM, et al. Danshen (Salvia miltiorrhiza) protects ovariectomized rats fed with high-saturated fat-sucrose diet from bone loss. Osteoporos Int. 2017;29(1):223–235. doi:10.1007/s00198-017-4254-229058051
   PubMed Web of Science ®Google Scholar
• KwokT, LeungPC, LamC, et al. A randomized placebo controlled trial of an innovative herbal formula in the prevention of atherosclerosis in postmenopausal women with borderline hypercholesterolemia. Complement Ther Med. 2014;22(3):473–480. doi:10.1016/j.ctim.2014.03.01024906587
   PubMed Web of Science ®Google Scholar
• Ren-anQ, JuanL, ChuyuanL, et al. Study of the protective mechanisms of compound danshen tablet (fufang danshen pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats. J Ethnopharmacol. 2014;156:190–198. doi:10.1016/j.jep.2014.08.02325178948
   PubMed Web of Science ®Google Scholar
• NaveedM, WenhuaL, GangW, et al. A novel ventricular restraint device (ASD) repetitively deliver Salvia miltiorrhiza to epicardium have good curative effects in heart failure management. Biomed Pharmacother. 2017;95:701–710. doi:10.1016/j.biopha.2017.07.12628886530
   PubMed Web of Science ®Google Scholar
• StumpfC, FanQ, HintermannC, et al. Anti-inflammatory effects ofdanshenon human vascular endothelial cells in culture. Am J Chin Med. 2013;41(05):1065–1077. doi:10.1142/S0192415X1350072924117069
   PubMed Web of Science ®Google Scholar
• ChenY-F, LeeN-H, PaiP-Y, et al. Tanshinone-induced ERs suppresses IGFII activation to alleviate Ang II-mediated cardiac hypertrophy. J Receptors Signal Transduction. 2017;37(5):493–499. doi:10.1080/10799893.2017.1360349
   PubMed Web of Science ®Google Scholar
• zhangX, MaZ, LiangQ, et al. Tanshinone IIA exerts protective effects in a LCA-induced cholestatic liver model associated with participation of pregnane X receptor. J Ethnopharmacol. 2015;164:357–367. doi:10.1016/j.jep.2015.01.04725660334
   PubMed Web of Science ®Google Scholar
• LuoJ, SongW, YangG, XuH, ChenK. Compound Danshen (Salvia miltiorrhiza) dripping pill for coronary heart disease: an overview of systematic reviews. Am J Chin Med. 2015;43(1):25–43. doi:10.1142/S0192415X1550002025582415
   PubMed Web of Science ®Google Scholar
• Wing-Shing CheungD, KoonC-M, NgC-F, et al. The roots of Salvia miltiorrhiza (Danshen) and Pueraria lobata (Gegen) inhibit atherogenic events: A study of the combination effects of the 2-herb formula. J Ethnopharmacol. 2012;143(3):859–866. doi:10.1016/j.jep.2012.08.01122922086
   PubMed Web of Science ®Google Scholar
• ShangQ, XuH, HuangL. Tanshinone IIA: A promising natural cardioprotective agent. Evid Based Complement Alternat Med. 2012;2012:716459. doi:10.1155/2012/71645922454677
   PubMed Web of Science ®Google Scholar
• Domínguez-AndrésJ, JoostenLAB, NeteaMG. Induction of innate immune memory: the role of cellular metabolism. Curr Opin Immunol. 2019;56:10–16. doi:10.1016/j.coi.2018.09.00130240964
   PubMed Web of Science ®Google Scholar
• CollinM, BigleyV. Human dendritic cell subsets: an update. Immunology. 2018;154(1):3–20.29313948
   PubMed Web of Science ®Google Scholar
• GongY, LiuY-C, DingX-L, FuY, CuiL-J, YanY-P. Tanshinone IIA ameliorates CNS autoimmunity by promoting the differentiation of regulatory T cells. Neurotherapeutics. 2020;17(2):690–703. doi:10.1007/s13311-019-00789-231845175
   PubMed Web of Science ®Google Scholar
• LiHZ, LuYH, HuangGS, ChenQ, FuQ, LiZL. Tanshinone II A inhibits dendritic cell-mediated adaptive immunity: potential role in anti-atherosclerotic activity. Chin J Integr Med. 2014;20(10):764–769. doi:10.1007/s11655-012-1213-923001464
   PubMed Web of Science ®Google Scholar
• LarsonSR, AtifSM, GibbingsSL, et al. Ly6C(+) monocyte efferocytosis and cross-presentation of cell-associated antigens. Cell Death Differ. 2016;23(6):997–1003. doi:10.1038/cdd.2016.2426990659
   PubMed Web of Science ®Google Scholar
• MontoroJ, PinanaJL, SanzJ, GuerreiroM. T lymphocytes as therapeutic arsenal for patients with hematological malignancies. Curr Opin Oncol. 2018;30(6):425–434.30124521
   PubMed Web of Science ®Google Scholar
• DoitshG, GreeneWC. Dissecting how CD4 T cells are lost during HIV infection. Cell Host Microbe. 2016;19(3):280–291. doi:10.1016/j.chom.2016.02.01226962940
   PubMed Web of Science ®Google Scholar
• QinXY, LiT, YanL, LiuQS, TianY. Tanshinone IIA protects against immune-mediated liver injury through activation of T-cell subsets and regulation of cytokines. Immunopharmacol Immunotoxicol. 2010;32(1):51–55. doi:10.3109/0892397090312099719653860
   PubMed Web of Science ®Google Scholar
• YanJ, YangX, HanD, FengJ. Tanshinone IIA attenuates experimental autoimmune encephalomyelitis in rats. Mol Med Rep. 2016;14(2):1601–1609. doi:10.3892/mmr.2016.543127357729
   PubMed Web of Science ®Google Scholar
• OuyangW, O’GarraA. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 2019;50(4):871–891. doi:10.1016/j.immuni.2019.03.02030995504
   PubMed Web of Science ®Google Scholar
• GeY, HuangM, YaoYM. Autophagy and proinflammatory cytokines: interactions and clinical implications. Cytokine Growth Factor Rev. 2018;43:38–46. doi:10.1016/j.cytogfr.2018.07.00130031632
   PubMed Web of Science ®Google Scholar
• MusolinoC, AllegraA, InnaoV, AllegraAG, PioggiaG, GangemiS. Inflammatory and anti-inflammatory equilibrium, proliferative and antiproliferative balance: the role of cytokines in multiple myeloma. Mediators Inflamm. 2017;2017:1852517. doi:10.1155/2017/185251729089667
   PubMed Web of Science ®Google Scholar
• ZhangB, YuY, AoriG, et al. Tanshinone IIA attenuates diabetic peripheral neuropathic pain in experimental rats via inhibiting inflammation. Evid Based Complement Alternat Med. 2018;2018:2789847.29713362
   PubMed Web of Science ®Google Scholar
• YoshimuraA, ItoM, ChikumaS, AkanumaT, NakatsukasaH. Negative regulation of cytokine signaling in immunity. Cold Spring Harb Perspect Biol. 2018;10:7. doi:10.1101/cshperspect.a028571
   Web of Science ®Google Scholar
• RajaJ, DentonCP. Cytokines in the immunopathology of systemic sclerosis. Semin Immunopathol. 2015;37(5):543–557. doi:10.1007/s00281-015-0511-726152640
   PubMed Web of Science ®Google Scholar
• AnthoneyN, FoldiI, HidalgoA. Toll and Toll-like receptor signalling in development. Development. 2018;145(9):dev156018. doi:10.1242/dev.15601829695493
   PubMed Web of Science ®Google Scholar
• ZhaoX, HuoR, YanX, XuT. IRF3 negatively regulates toll-like receptor-mediated NF-κB signaling by targeting TRIF for degradation in teleost fish. Front Immunol. 2018;9:867. doi:10.3389/fimmu.2018.0086729755465
   PubMed Web of Science ®Google Scholar
• MengZ, SiCY, TengS, YuXH, LiHY. Tanshinone IIA inhibits lipopolysaccharide‑induced inflammatory responses through the TLR4/TAK1/NF‑κB signaling pathway in vascular smooth muscle cells. Int J Mol Med. 2019. doi:10.3892/ijmm.2019.4100
   Web of Science ®Google Scholar
• FangC, XieL, LiuC, et al. Tanshinone IIA improves hypoxic ischemic encephalopathy through TLR4mediated NFkappaB signal pathway. Mol Med Rep. 2018;18(2):1899–1908.29956801
   PubMed Web of Science ®Google Scholar
• DuH, WangY, ZengY, et al. Tanshinone IIA suppresses proliferation and inflammatory cytokine production of synovial fibroblasts from rheumatoid arthritis patients induced by TNF-alpha and attenuates the inflammatory response in AIA mice. Front Pharmacol. 2020;11:568. doi:10.3389/fphar.2020.0056832499694
   PubMed Web of Science ®Google Scholar
• AchkarIW, AbdulrahmanN, Al-SulaitiH, JosephJM, UddinS, MraicheF. Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway. J Transl Med. 2018;16(1):96. doi:10.1186/s12967-018-1471-129642900
   PubMed Web of Science ®Google Scholar
• LiH, HanW, WangH, et al. Tanshinone IIA inhibits glutamate-induced oxidative toxicity through prevention of mitochondrial dysfunction and suppression of MAPK activation in SH-SY5Y human neuroblastoma cells. Oxid Med Cell Longev. 2017;2017:4517486. doi:10.1155/2017/451748628690763
   PubMed Web of Science ®Google Scholar
• FangJ, ChenQ, HeB, et al. Tanshinone IIA attenuates TNF-α induced PTX3 expression and monocyte adhesion to endothelial cells through the p38/NF-κB pathway. Food Chem Toxicol. 2018;121:622–630. doi:10.1016/j.fct.2018.09.06330268796
   PubMed Web of Science ®Google Scholar
• Aluganti NarasimhuluC, Fernandez-RuizI, SelvarajanK, et al. Atherosclerosis–do we know enough already to prevent it? Curr Opin Pharmacol. 2016;27:92–102. doi:10.1016/j.coph.2016.02.00626974701
   PubMed Web of Science ®Google Scholar
• GisteraA, HanssonGK. The immunology of atherosclerosis. Nat Rev Nephrol. 2017;13(6):368–380. doi:10.1038/nrneph.2017.5128392564
   PubMed Web of Science ®Google Scholar
• LibbyP, HanssonGK. Inflammation and immunity in diseases of the arterial tree: players and layers. Circ Res. 2015;116(2):307–311. doi:10.1161/CIRCRESAHA.116.30131325593275
   PubMed Web of Science ®Google Scholar
• DronJS, LazarteJ, HegeleRA. Recent Highlights ofATVB. Arterioscler Thromb Vasc Biol. 2018;38:11. doi:10.1161/ATVBAHA.118.311581
   Web of Science ®Google Scholar
• HartleyA, HaskardD, KhamisR. Oxidized LDL and anti-oxidized LDL antibodies in atherosclerosis – novel insights and future directions in diagnosis and therapy. Trends Cardiovasc Med. 2019;29(1):22–26. doi:10.1016/j.tcm.2018.05.01029934015
   PubMed Web of Science ®Google Scholar
• AhmadseiM, LievensD, WeberC, von HundelshausenP, GerdesN. Immune-mediated and lipid-mediated platelet function in atherosclerosis. Curr Opin Lipidol. 2015;26(5):438–448. doi:10.1097/MOL.000000000000021226270811
   PubMed Web of Science ®Google Scholar
• TabasI, BornfeldtKE. Macrophage phenotype and function in different stages of atherosclerosis. Circ Res. 2016;118(4):653–667.26892964
   PubMed Web of Science ®Google Scholar
• FavaC, MontagnanaM. Atherosclerosis is an inflammatory disease which lacks a common anti-inflammatory therapy: how human genetics can help to this issue. A narrative review. Front Pharmacol. 2018;9:55. doi:10.3389/fphar.2018.0005529467655
   PubMed Web of Science ®Google Scholar
• Chang-C-C, ChuC-F, WangC-N, et al. The anti-atherosclerotic effect of tanshinone IIA is associated with the inhibition of TNF-α-induced VCAM-1, ICAM-1 and CX3CL1 expression. Phytomedicine. 2014;21(3):207–216. doi:10.1016/j.phymed.2013.09.01224157079
   PubMed Web of Science ®Google Scholar
• WangB, GeZ, ChengZ, ZhaoZ. Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDL. Biol Open. 2017;6(4):489–495. doi:10.1242/bio.02413328412716
   PubMed Web of Science ®Google Scholar
• XuS, LittlePJ, LanT, et al. Tanshinone II-A attenuates and stabilizes atherosclerotic plaques in apolipoprotein-E knockout mice fed a high cholesterol diet. Arch Biochem Biophys. 2011;515(12):72–79. doi:10.1016/j.abb.2011.08.00621889487
   PubMed Web of Science ®Google Scholar
• ZhaoD, TongL, ZhangL, LiH, WanY, ZhangT. Tanshinone II A stabilizes vulnerable plaques by suppressing RAGE signaling and NF-kappaB activation in apolipoprotein-E-deficient mice. Mol Med Rep. 2016;14:4983–4990. doi:10.3892/mmr.2016.591627840935
   PubMed Web of Science ®Google Scholar
• Chen W, Li X, Guo S, et al. Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375/KLF4 pathway to attenuate atherosclerosis. Int Immunopharmacol. 2019;70:486–497.
   Google Scholar
• ColeJE, KassiteridiC, MonacoC. Toll-like receptors in atherosclerosis: a ‘Pandora’s box’ of advances and controversies. Trends Pharmacol Sci. 2013;34(11):629–636. doi:10.1016/j.tips.2013.09.00824139612
   PubMed Web of Science ®Google Scholar
• ChenZ, GaoX, JiaoY, et al. Tanshinone iia exerts anti-inflammatory and immune-regulating effects on vulnerable atherosclerotic plaque partially via the TLR4/MyD88/NF-κB signal pathway. Front Pharmacol. 2019;10:850. doi:10.3389/fphar.2019.0085031402870
   PubMed Web of Science ®Google Scholar
• FanG, JiangX, WuX, et al. Anti-inflammatory activity of tanshinone IIA in LPS-stimulated RAW264.7 macrophages via miRNAs and TLR4–NF-κB pathway. Inflammation. 2015;39(1):375–384. doi:10.1007/s10753-015-0259-1
   Web of Science ®Google Scholar
• KongD-H, KimYK, KimMR, JangJH, LeeS. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in Immunological disorders and cancer. Int J Mol Sci. 2018;19(4):1057.
   PubMed Web of Science ®Google Scholar
• FosterCA. VCAM-1/alpha 4-integrin adhesion pathway: therapeutic target for allergic inflammatory disorders. J Allergy Clin Immunol. 1996;98(6 Pt 2):S270277. doi:10.1016/S0091-6749(96)70075-1
   Web of Science ®Google Scholar
• ZhuJ, XuY, RenG, et al. Tanshinone IIA Sodium sulfonate regulates antioxidant system, inflammation, and endothelial dysfunction in atherosclerosis by downregulation of CLIC1. Eur J Pharmacol. 2017;815:427–436. doi:10.1016/j.ejphar.2017.09.04728970012
   PubMed Web of Science ®Google Scholar
• JiaG, HillMA, SowersJR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624–638. doi:10.1161/CIRCRESAHA.117.31158629449364
   PubMed Web of Science ®Google Scholar
• MudauM, GenisA, LochnerA, StrijdomH. Endothelial dysfunction: the early predictor of atherosclerosis. Cardiovasc J Afr. 2012;23(4):222–231. doi:10.5830/CVJA-2011-06822614668
   PubMed Web of Science ®Google Scholar
• ChenL, GuoQ-H, ChangY, ZhaoY-S, LiA-Y, JiE-S. Tanshinone IIA ameliorated endothelial dysfunction in rats with chronic intermittent hypoxia. Cardiovasc Pathol. 2017;31:47–53. doi:10.1016/j.carpath.2017.06.00828985491
   PubMed Web of Science ®Google Scholar
• QianS, QianY, HuoD, WangS, QianQ. Tanshinone IIa protects retinal endothelial cells against mitochondrial fission induced by methylglyoxal through glyoxalase 1. Eur J Pharmacol. 2019;857:172419. doi:10.1016/j.ejphar.2019.17241931136758
   PubMed Web of Science ®Google Scholar
• ZhuJ, LiaoS, ZhouL, WanL. Tanshinone IIA attenuates Aβ25-35-induced spatial memory impairment via upregulating receptors for activated C kinase1 and inhibiting autophagy in hippocampus. J Pharm Pharmacol. 2016;69(2):191–201. doi:10.1111/jphp.1265027882565
   PubMed Web of Science ®Google Scholar
• TangF, WuX, WangT, et al. Tanshinone II A attenuates atherosclerotic calcification in rat model by inhibition of oxidative stress. Vascul Pharmacol. 2007;46(6):427–438. doi:10.1016/j.vph.2007.01.00117337361
   PubMed Web of Science ®Google Scholar
• LiY-I, ElmerG, LeboeufRC. Tanshinone IIA reduces macrophage death induced by hydrogen peroxide by upregulating glutathione peroxidase. Life Sci. 2008;83(1516):557–562. doi:10.1016/j.lfs.2008.08.00318762198
   PubMed Web of Science ®Google Scholar
• PirilloA, NorataGD, CatapanoAL. LOX-1, OxLDL, and atherosclerosis. Mediators Inflamm. 2013;2013:152786. doi:10.1155/2013/15278623935243
   PubMed Web of Science ®Google Scholar
• ChengX, ZhangD-L, LiX-B, et al. Syntheses of diacyltanshinol derivatives and their suppressive effects on macrophage foam cell formation by reducing oxidized LDL uptake. Bioorg Chem. 2014;52:24–30. doi:10.1016/j.bioorg.2013.11.00124300390
   PubMed Web of Science ®Google Scholar
• TaoZ, ShiA, ZhaoJ. Epidemiological Perspectives of Diabetes. Cell Biochem Biophys. 2015;73(1):181–185. doi:10.1007/s12013-015-0598-425711186
   PubMed Web of Science ®Google Scholar
• YuanFY, ZhangM, XuP, et al. Tanshinone IIA improves diabetes mellitus via the NF-kappaB-induced AMPK signal pathway. Exp Ther Med. 2018;16(5):4225–4231.30344697
   PubMed Web of Science ®Google Scholar
• LiFQ, ZengDK, JiaCL, et al. The effects of sodium tanshinone IIa sulfonate pretreatment on high glucose-induced expression of fractalkine and apoptosis in human umbilical vein endothelial cells. Int J Clin Exp Med. 2015;8(4):5279–5286.26131102
   PubMed Web of Science ®Google Scholar
• ZhuQ, ZengD, LiF. Ghrelin combined with sodium tanshinone IIA sulfonate pretreatment reduces apoptosis and fractalkine expression induced by high-dose glucose in human umbilical vein endothelial cells. Minerva Endocrinol. 2019.
   Web of Science ®Google Scholar
• PanC, LouL, HuoY, et al. Salvianolic acid B and Tanshinone IIA attenuate myocardial ischemia injury in mice by NO production through multiple pathways. Ther Adv Cardiovasc Dis. 2011;5(2):99–111. doi:10.1177/175394471039653821282198
   PubMedGoogle Scholar
• LiY-H, XuQ, XuW-H, GuoX-H, ZhangS, ChenY-D. Mechanisms of protection against diabetes-induced impairment of endothelium-dependent vasorelaxation by Tanshinone IIA. Biochimica et Biophysica Acta. 2015;1850(4):813–823. doi:10.1016/j.bbagen.2015.01.00725613563
   PubMed Web of Science ®Google Scholar
• FanK, LiS, LiuG, YuanH, MaL, LuP. Tanshinone IIA inhibits high glucose-induced proliferation, migration and vascularization of human retinal endothelial cells. Mol Med Rep. 2017;16(6):9023–9028. doi:10.3892/mmr.2017.774329039498
   PubMed Web of Science ®Google Scholar
• ChenX, WuR, KongY, et al. Tanshinone IIA attenuates renal damage in STZ-induced diabetic rats via inhibiting oxidative stress and inflammation. Oncotarget. 2017;8(19):31915–31922. doi:10.18632/oncotarget.1665128404881
   PubMedGoogle Scholar
• ChenJ, BiY, ChenL, ZhangQ, XuL. Tanshinone IIA exerts neuroprotective effects on hippocampus-dependent cognitive impairments in diabetic rats by attenuating ER stress-induced apoptosis. Biomed Pharmacother. 2018;104:530–536. doi:10.1016/j.biopha.2018.05.04029800917
   PubMed Web of Science ®Google Scholar
• PilipenkoV, NarbuteK, AmaraI, et al. GABA‐containing compound gammapyrone protects against brain impairments in Alzheimer’s disease model male rats and prevents mitochondrial dysfunction in cell culture. J Neurosci Res. 2019;97(6):708–726. doi:10.1002/jnr.2439630742328
   PubMed Web of Science ®Google Scholar
• Di RosaG, BrunettiG, ScutoM, et al. Healthspan enhancement by olive polyphenols in c. elegans wild type and parkinson’s models. Int J Mol Sci. 2020;21:11. doi:10.3390/ijms21113893
   Web of Science ®Google Scholar
• WuTY, ChenCP, JinnTR. Traditional Chinese medicines and Alzheimer’s disease. Taiwan J Obstet Gynecol. 2011;50(2):131–135. doi:10.1016/j.tjog.2011.04.00421791295
   PubMed Web of Science ®Google Scholar
• CalabreseV, CorneliusC, Dinkova-KostovaAT, CalabreseEJ, MattsonMP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid Redox Signal. 2010;13(11):1763–1811. doi:10.1089/ars.2009.307420446769
   PubMed Web of Science ®Google Scholar
• KnappM, TuX, WuR. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy. Acta Pharmacol Sin. 2019;40(1):1–8. doi:10.1038/s41401-018-0042-629867137
   PubMed Web of Science ®Google Scholar
• CalabreseV, SantoroA, MontiD, et al. Aging and Parkinson’s Disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med. 2018;115:80–91. doi:10.1016/j.freeradbiomed.2017.10.37929080843
   PubMed Web of Science ®Google Scholar
• MizamtsidiM, PaschouSA, GrapsaJ, VryonidouA. Diabetic cardiomyopathy: a clinical entity or a cluster of molecular heart changes? Eur J Clin Invest. 2016;46(11):947–953.27600276
   PubMed Web of Science ®Google Scholar
• LiuT, JinH, SunQ-R, XuJ-H, HuH-T. The neuroprotective effects of tanshinone IIA on β-amyloid-induced toxicity in rat cortical neurons. Neuropharmacology. 2010;59(78):595–604. doi:10.1016/j.neuropharm.2010.08.01320800073
   PubMed Web of Science ®Google Scholar
• Di GiacomoV, ChiavaroliA, RecinellaL, et al. Antioxidant and neuroprotective effects induced by cannabidiol and cannabigerol in rat CTX-TNA2 astrocytes and isolated cortexes. Int J Mol Sci. 2020;21:10. doi:10.3390/ijms21103575
   Web of Science ®Google Scholar
• CalabreseV, SantoroA, Trovato SalinaroA, et al. Hormetic approaches to the treatment of Parkinson’s disease: perspectives and possibilities. J Neurosci Res. 2018;96(10):1641–1662. doi:10.1002/jnr.2424430098077
   PubMed Web of Science ®Google Scholar
• LinL, JadoonSS, LiuS-Z, et al. Tanshinone IIA ameliorates spatial learning and memory deficits by inhibiting the activity of ERK and GSK-3β. J Geriatr Psychiatry Neurol. 2019;32(3):152–163. doi:10.1177/089198871983737330885037
   PubMed Web of Science ®Google Scholar
• LiuC, WuY, ZhaS, et al. Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice. Brain Res. 2016;1631:137–146. doi:10.1016/j.brainres.2015.11.04026656068
   PubMed Web of Science ®Google Scholar
• LiK, WeiQ, Liu-F-F, et al. Synaptic dysfunction in alzheimer’s disease: aβ, tau, and epigenetic alterations. Mol Neurobiol. 2017;55(4):3021–3032. doi:10.1007/s12035-017-0533-328456942
   PubMed Web of Science ®Google Scholar
• QianYH, XiaoQ, XuJ. The protective effects of tanshinone IIA on beta-amyloid protein (142)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron. Brain Res Bull. 2012;88(4):354–358. doi:10.1016/j.brainresbull.2012.03.00722498308
   PubMed Web of Science ®Google Scholar
• LiJ, WangF, ZhouJ, LiW. [Effects of tanshinone IIA on the expressions of p53, pp53 and apoptosis in the rats with Alzheimer’s disease]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015;40(11):1210–1216. Chinese.26643424
   PubMedGoogle Scholar
• CalabreseEJ. A FAILED CANCER PARADIGM: implications for cancer risk assessment and patients. J Cell Commun Signal. 2019;13(3):271–272. doi:10.1007/s12079-019-00526-631385200
   PubMed Web of Science ®Google Scholar
• ChenG, LiangY, LiangX, LiQ, LiuD. Tanshinone IIA inhibits proliferation and induces apoptosis through the downregulation of survivin in keloid fibroblasts. Ann Plast Surg. 2016;76(2):180–186. doi:10.1097/SAP.000000000000054426101974
   PubMed Web of Science ®Google Scholar
• BaiY, ZhangL, FangX, YangY. Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-kappaB. Exp Ther Med. 2016;11(3):1085–1089. doi:10.3892/etm.2016.298426998041
   PubMed Web of Science ®Google Scholar
• ChiuS-C, HuangS-Y, ChangS-F, et al. Potential therapeutic roles of tanshinone IIA in human bladder cancer cells. Int J Mol Sci. 2014;15(9):15622–15637.25192287
   PubMed Web of Science ®Google Scholar
• YuJ, WangX, LiY, TangB. Tanshinone IIA suppresses gastric cancer cell proliferation and migration by downregulation of FOXM1. Oncol Rep. 2017;37(3):1394–1400. doi:10.3892/or.2017.540828184921
   PubMed Web of Science ®Google Scholar
• ChiuSC, HuangSY, ChangSF, et al. Potential therapeutic roles of tanshinone IIA in human bladder cancer cells. Int J Mol Sci. 2014;15:15622–15637. doi:10.3390/ijms15091562225192287
   PubMed Web of Science ®Google Scholar
• WhiteWL. Erratum to: why I hate the index finger. Hand. 2011;6(2):233. doi:10.1007/s11552-011-9321-021776199
   PubMedGoogle Scholar
• WangT, WangC, WuQ, et al. Evaluation of tanshinone IIA developmental toxicity in zebrafish embryos. Molecules. 2017;22(4):660. doi:10.3390/molecules22040660
   PubMed Web of Science ®Google Scholar
• WangM, LiuJ, ZhouB, et al. Acute and sub-chronic toxicity studies of danshen injection in sprague-dawley rats. J Ethnopharmacol. 2012;141(1):96–103. doi:10.1016/j.jep.2012.02.00522343168
   PubMed Web of Science ®Google Scholar